Literature DB >> 6624791

Ritodrine hydrochloride infusion in pregnant baboons. II. Sodium and water compartment alterations.

G D Hankins, J C Hauth, T J Kuehl, Y W Brans, F G Cunningham, W Pierson.   

Abstract

To evaluate the effects of intravenously administered ritodrine hydrochloride on sodium and water metabolism, a pregnant baboon model was studied. Animals given ritodrine retained significantly more sodium (p less than 0.001) and administered fluids (p less than 0.002) compared with control animals. Although plasma volume did not change significantly within or between the two groups, extracellular volume increased by a mean of 1,480 ml in those given ritodrine compared with 790 ml in the control animals. There was no significant difference between animals given ritodrine and their controls regarding serial hematocrits, serum sodium, or colloid oncotic pressures. From this we conclude that the retained sodium and water was in the interstitial space. Since plasma volume was unaltered by ritodrine administration it seems unlikely that pure volume overload can explain the pulmonary edema induced by beta-mimetics. Combined with the prior observation that direct pulmonary capillary membrane toxicity does not occur, the likely pathophysiology of beta-agonist-induced pulmonary edema involves left ventricular failure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624791     DOI: 10.1016/0002-9378(83)91107-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  The effects of ritodrine on prostaglandin metabolite concentrations in the blood of pregnant baboons.

Authors:  G D Hankins; D M Strickland; J C Hauth; T J Kuehl; M D Mitchell
Journal:  Arch Gynecol       Date:  1983

2.  Anaesthesia for caesarean section in a parturient with quintuplet gestation, pulmonary oedema and thrombocytopaenia.

Authors:  E T Crosby; R D Elliott
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.